These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

708 related items for PubMed ID: 16203787

  • 1. In vivo evaluation of ixabepilone (BMS247550), a novel epothilone B derivative, against pediatric cancer models.
    Peterson JK, Tucker C, Favours E, Cheshire PJ, Creech J, Billups CA, Smykla R, Lee FY, Houghton PJ.
    Clin Cancer Res; 2005 Oct 01; 11(19 Pt 1):6950-8. PubMed ID: 16203787
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase I study of the novel epothilone analog ixabepilone (BMS-247550) in patients with advanced solid tumors and lymphomas.
    Aghajanian C, Burris HA, Jones S, Spriggs DR, Cohen MB, Peck R, Sabbatini P, Hensley ML, Greco FA, Dupont J, O'Connor OA.
    J Clin Oncol; 2007 Mar 20; 25(9):1082-8. PubMed ID: 17261851
    [Abstract] [Full Text] [Related]

  • 5. Preclinical efficacy spectrum and pharmacokinetics of ixabepilone.
    Lee FY, Smykla R, Johnston K, Menard K, McGlinchey K, Peterson RW, Wiebesiek A, Vite G, Fairchild CR, Kramer R.
    Cancer Chemother Pharmacol; 2009 Jan 20; 63(2):201-12. PubMed ID: 18350296
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 20; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 7. Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy.
    Awada A, Piccart MJ, Jones SF, Peck RA, Gil T, Lebwohl D, Wu CY, Burris HA.
    Cancer Chemother Pharmacol; 2009 Feb 20; 63(3):417-25. PubMed ID: 18446338
    [Abstract] [Full Text] [Related]

  • 8. Preclinical discovery of ixabepilone, a highly active antineoplastic agent.
    Lee FY, Borzilleri R, Fairchild CR, Kamath A, Smykla R, Kramer R, Vite G.
    Cancer Chemother Pharmacol; 2008 Dec 20; 63(1):157-66. PubMed ID: 18347795
    [Abstract] [Full Text] [Related]

  • 9. Synergy of topotecan in combination with vincristine for treatment of pediatric solid tumor xenografts.
    Thompson J, George EO, Poquette CA, Cheshire PJ, Richmond LB, de Graaf SS, Ma M, Stewart CF, Houghton PJ.
    Clin Cancer Res; 1999 Nov 20; 5(11):3617-31. PubMed ID: 10589779
    [Abstract] [Full Text] [Related]

  • 10. Phase I clinical trial and pharmacokinetic study of the spicamycin analog KRN5500 administered as a 1-hour intravenous infusion for five consecutive days to patients with refractory solid tumors.
    Supko JG, Eder JP, Ryan DP, Seiden MV, Lynch TJ, Amrein PC, Kufe DW, Clark JW.
    Clin Cancer Res; 2003 Nov 01; 9(14):5178-86. PubMed ID: 14613997
    [Abstract] [Full Text] [Related]

  • 11. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM.
    Oncologist; 1997 Nov 01; 2(1):I-II. PubMed ID: 10388032
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy and safety of ixabepilone (BMS-247550), a novel epothilone B analogue].
    Villanueva C, Dufresne A, Pivot X, Viel E.
    Bull Cancer; 2008 Feb 01; 95(2):197-204. PubMed ID: 18304905
    [Abstract] [Full Text] [Related]

  • 13. Phase I dose-finding study of weekly single-agent patupilone in patients with advanced solid tumors.
    Rubin EH, Rothermel J, Tesfaye F, Chen T, Hubert M, Ho YY, Hsu CH, Oza AM.
    J Clin Oncol; 2005 Dec 20; 23(36):9120-9. PubMed ID: 16301595
    [Abstract] [Full Text] [Related]

  • 14. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA.
    Clin Cancer Res; 2001 May 20; 7(5):1429-37. PubMed ID: 11350914
    [Abstract] [Full Text] [Related]

  • 15. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR.
    Clin Cancer Res; 1997 Nov 20; 3(11):2063-74. PubMed ID: 9815598
    [Abstract] [Full Text] [Related]

  • 16. Phase I and pharmacokinetic study of E7070, a chloroindolyl-sulfonamide anticancer agent, administered on a weekly schedule to patients with solid tumors.
    Dittrich C, Dumez H, Calvert H, Hanauske A, Faber M, Wanders J, Yule M, Ravic M, Fumoleau P.
    Clin Cancer Res; 2003 Nov 01; 9(14):5195-204. PubMed ID: 14613999
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
    Blaney SM, Needle MN, Gillespie A, Sato JK, Reaman GH, Berg SL, Adamson PC, Krailo MD, Bleyer WA, Poplack DG, Balis FM.
    Clin Cancer Res; 1998 Feb 01; 4(2):357-60. PubMed ID: 9516923
    [Abstract] [Full Text] [Related]

  • 18. Ixabepilone: a novel microtubule inhibitor for the treatment of locally advanced or metastatic breast cancer.
    Steinberg M.
    Clin Ther; 2008 Sep 01; 30(9):1590-617. PubMed ID: 18840366
    [Abstract] [Full Text] [Related]

  • 19. A phase I and pharmacokinetic study of ixabepilone in combination with Carboplatin in patients with advanced solid malignancies.
    Plummer R, Woll P, Fyfe D, Boddy AV, Griffin M, Hewitt P, Carmichael J, Namouni F, Cohen M, Verrill M.
    Clin Cancer Res; 2008 Dec 15; 14(24):8288-94. PubMed ID: 19088046
    [Abstract] [Full Text] [Related]

  • 20. Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors.
    Rivera E, Lee J, Davies A.
    Oncologist; 2008 Dec 15; 13(12):1207-23. PubMed ID: 19088324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.